04.10.2014 Views

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Firstly, break<strong>in</strong>g up Vhi <strong>Health</strong>care would be expected to impact on <strong>the</strong><br />

cost of private health <strong>in</strong>surance <strong>in</strong> a number of different ways. As<br />

noted above <strong>the</strong> expected <strong>in</strong>creased level of competition would be<br />

expected to lead to <strong>in</strong>creased allocative and dynamic efficiencies,<br />

although <strong>the</strong> extent of such efficiency ga<strong>in</strong>s is unclear and needs to be<br />

assessed. Break<strong>in</strong>g up Vhi <strong>Health</strong>care could also give rise to a number<br />

of costs, which could cause <strong>the</strong> cost of private health <strong>in</strong>surance to<br />

<strong>in</strong>crease, for <strong>the</strong> follow<strong>in</strong>g reasons:<br />

• Economies of scale <strong>in</strong> <strong>the</strong> <strong>in</strong>dustry would be reduced, as a number<br />

of different functions would be replicated <strong>in</strong> each of <strong>the</strong> new<br />

<strong>in</strong>surers.<br />

• The buy<strong>in</strong>g power of <strong>in</strong>surers would be reduced relative to <strong>the</strong><br />

market power of healthcare providers. The barga<strong>in</strong><strong>in</strong>g position of<br />

<strong>in</strong>surers would be weakened <strong>in</strong> <strong>the</strong>ir deal<strong>in</strong>gs with hospitals and<br />

consultants and consequently <strong>the</strong> costs of healthcare services may<br />

<strong>in</strong>crease.<br />

• Vhi <strong>Health</strong>care operates on a not-for-profit basis. The new <strong>in</strong>surers<br />

might not operate on such a basis and this may have consequent<br />

effects on <strong>the</strong> cost of health <strong>in</strong>surance.<br />

• There would be transitional costs associated with <strong>the</strong> break-up of<br />

Vhi <strong>Health</strong>care and <strong>the</strong> establishment of <strong>the</strong> new <strong>in</strong>surers.<br />

• If <strong>the</strong> Vhi <strong>Health</strong>care brand was to be ext<strong>in</strong>guished, this could<br />

represent a direct loss to consumers, ma<strong>in</strong>ly because <strong>the</strong> new<br />

successor Vhi companies would have to spend significant amounts<br />

on advertis<strong>in</strong>g to create and build up new corporate identities.<br />

9.9 Secondly, <strong>the</strong>re are a number of risks and uncerta<strong>in</strong>ties associated<br />

with break<strong>in</strong>g up Vhi <strong>Health</strong>care. In particular, risk equalisation<br />

cont<strong>in</strong>ues to be <strong>the</strong> subject of court challenge. If <strong>the</strong>se challenges<br />

were to succeed, <strong>the</strong> viability of <strong>the</strong> new <strong>in</strong>surers would be <strong>in</strong> grave<br />

doubt. Indeed, <strong>in</strong> such circumstances <strong>the</strong>y may not be <strong>in</strong> a position to<br />

receive authorisation from <strong>the</strong> f<strong>in</strong>ancial regulator. Fur<strong>the</strong>rmore,<br />

possible impacts on o<strong>the</strong>r related areas of Government health strategy<br />

would need to be assessed.<br />

9.10 Thirdly, a number of practical feasibility issues would need to be<br />

considered, <strong>in</strong>clud<strong>in</strong>g <strong>the</strong> follow<strong>in</strong>g:<br />

• How would Vhi <strong>Health</strong>care be broken up? Into how many<br />

companies would it be broken up? How would <strong>the</strong> assets and<br />

memberships be split? Issues arise <strong>in</strong> relation to <strong>the</strong> ownership<br />

and control of <strong>the</strong> new <strong>in</strong>surers. How would <strong>the</strong> assets of Vhi<br />

<strong>Health</strong>care and its memberships be split?<br />

• Where would <strong>the</strong> new <strong>in</strong>surers receive <strong>the</strong>ir f<strong>in</strong>ancial capital? Is it<br />

available <strong>in</strong> <strong>the</strong> f<strong>in</strong>ancial markets and if so at what cost? How<br />

would <strong>the</strong> cost of remunerat<strong>in</strong>g this capital affect <strong>the</strong> cost of health<br />

<strong>in</strong>surance?<br />

• How would systems be distributed between <strong>the</strong> new companies? Is<br />

<strong>the</strong>re sufficient expertise available to establish run and ma<strong>in</strong>ta<strong>in</strong><br />

<strong>the</strong>se systems <strong>in</strong> each of <strong>the</strong> new companies? How would this<br />

135

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!